首页> 外文期刊>BMC Cancer >The value of 3D visualization operative planning system in ultrasound-guided percutaneous microwave ablation for large hepatic hemangiomas: a clinical comparative study
【24h】

The value of 3D visualization operative planning system in ultrasound-guided percutaneous microwave ablation for large hepatic hemangiomas: a clinical comparative study

机译:大型肝血管瘤超声引导微波消融3D可视化术治疗系统的价值:临床比较研究

获取原文
           

摘要

To evaluate the value of a three dimension (3D)visualization operative planning system in ultrasound-guided percutaneous microwave ablation (US-PMWA) for large hepatic hemangiomas (LHHs). Fifty-eight patients with LHHs were divided into 3D and 2D groups. The therapeutic efficacy was assessed by contrast-enhanced imaging during follow-up. Hepatic and renal function were examined. The complete ablation, tumor volume shrinkage, and complication rates were analyzed. The ablation time and energy of the 3D group were lower than those of the 2D group (1152.0?±?403.9?s vs. 1379.7?±?375.8?s and 87,407.2.9?±?50,387.0?J vs. 117,775.8?±?46,245.6?J, P?=?0.031 and 0.021, respectively). The 3D group had a higher complete ablation rate than the 2D group (97.7?±?2.4% vs. 94.5?±?3.7%, P??0.001). The incidence of hemoglobinuria after ablation in the 3D group was lower than that in the 2D group (32.0% vs. 57.6%, P?=?0.047). The levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), and creatinine (Cre) after ablation in the 3D group were lower than those in the 2D group (126.7?±?56.4?U/L vs. 210.9?±?96.2?U/L, P??0.001; 141.0?±?60.8?U/L vs. 211.4?±?90.0?U/L, P?=?0.001; 57.3?±?17.6?U/L vs. 80.8?±?41.9?U/L, P?=?0.010; and 66.6?±?16.6?mmol/L vs. 84.5?±?39.6?mmol/L, P?=?0.037, respectively). There were no significant differences in antenna insertion and the volume reduction rate between the groups. One patient developed acute kidney injury shortly after ablation in the 2D group and recovered after hemodialysis. No other severe complications occurred during the follow-up period. The 3D visualization operative planning system has a relatively high clinical application value in providing scientific, reasonable, quantifiable, and individualized therapy for LHHs by US-PMWA.
机译:评估三维(3D)可视化操作规划系统的超声引导的经皮微波消融(US-PMWA)的价值进行大型肝血管瘤(LHHS)。将58名LHH患者分为3D和2D组。通过随访期间通过对比度增强的成像评估治疗效果。检查了肝癌和肾功能。分析完全消融,肿瘤体积收缩和并发症率。 3D组的消融时间和能量低于2D组(1152.0?±±403.9〜s与1379.7?±α?375.8?s和87,407.0.9?±67,775.8?±? 46,245.6?j,p?=?0.031和0.021)。 3D组的完全消融率高于2D组(97.7?±2.4%vs.94.5?±3.7%,p?<0.001)。在3D组中消融后血红蛋白尿尿尿的发病率低于2D组(32.0%与57.6%,P≤0.047)。在3D组中烧蚀后丙氨酸氨基转移酶(ALT),天冬氨酸氨基转移酶(AST),碱性磷酸酶(ALP)和肌酐(CRE)的水平低于2D组(126.7?±56.4〜56.4?U / L) vs. 210.9?±96.2?U / L,p?<?0.001; 141.0?±60.8?U / L vs. 211.4?±90.0?U / L,P?= 0.001; 57.3?57.3?57.3?57.3?57.3?57.3?57.3?57.3?57.3?57.3?57.3?57.3?57.3?57.3?57.3?57.3?57.3?57.3?57.3?57.3?57.3?57.3?57.3?57.3?57.3?57.3?57.3?57.3?57.3?57.3?57.3?57.3? ?U / L与80.8?±41.9?U / L,P?= 0.010;和66.6?±α?16.6?mmol / l与84.5?±39.6?mmol / l,p?= 0.037,分别)。天线插入没有显着差异和组之间的体积减小率。在2D组中消融后,一名患者短暂发育急性肾损伤,血液透析后恢复。随访期间没有发生其他严重的并发症。 3D可视化操作规划系统具有相对较高的临床应用价值,为US-PMWA提供了对LHHS的科学,合理,可量化和个性化的治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号